Working groups

PREVIOUS ACTIVITIES


ESCEO-FIRMO Symposium - Prevention of bone fractures in post-menopausal women treated with aromatase inhibitors for breast cancer
March 22, 2012

ESCEO-FROMO Symposium - Treatment of glucocortico•d-induced osteoporosis (GIOP)
March 22, 2012

ESCEO Symposium - Diagnosis and treatment of osteoarthritis: state of the art
March 23, 2012

ESCEO-FROMO Symposium - How to define responders in osteoarthritis?
March 23, 2012

ESCEO-ISPOR Symposium - Compliance with osteoporosis medications :
Causes of poor adherence; current statuts, clinical and economical consequences and interventions

March 23, 2012

ESCEO-FROMO Symposium - Treatment of osteoporosis in males
March 23, 2012

ESCEO-FROMO Symposium - Tools to assess frailty and sarcopenia
March 24, 2012

ESCEO-FROMO Symposium - Antidepressant medications and osteoporosis
March 24, 2012

ESCEO - Tools to assess frailty and sarcopenia
October 7, 2011

ESCEO - How to define responders in osteoarthritis?
September 23, 2011

ESCEO - Treatment of glucocorticoïd-induced osteoporosis (GIOP)
September 23, 2011

ESCEO - Antidepressant medications and osteoporosis
September 22, 2011

ESCEO - Treatment of osteoporosis in males
September 22, 2011

ESCEO-FROMO Symposium - Adverse reactions and drug-drug interactions in the management of osteoporosis
March 26, 2011

ESCEO-FROMO Symposium - Bone repair with anti-osteoporosis medications
March 26, 2011

ESCEO-FROMO Symposium - Frailty and Sarcopenia: State of the art
March 25, 2011

ESCEO-FROMO Symposium - Generic versus branded medication in osteoporosis: Are they really similar ?
March 25, 2011

ESCEO-FROMO Symposium - Recommendations for the design of clinical trials to be conducted by food and food supplements, in order to be granted the right to use health claims in osteoporosis (in collaboration with GREES)
March 25, 2011

ESCEO-FROMO Symposium - How should partial adherence be taken into account in health economic models in osteoporosis?
March 24, 2011

ESCEO-FROMO Symposium - Long-term treatment of osteoporosis
March 24, 2011

ESCEO-FROMO Symposium - Rheumatic diseases and bone
March 23, 2011

Prevention of bone fractures in postmenopausal women treated with aromatase inhibitors for breast cancer
February 11, 2011

Frailty and Sarcopenia: State of the Art
December 1, 2010

How should partial adherence be taken into account in health economic models in osteoporosis
December 1, 2010

Fracture Healing with current and new anti-osteoporotic medications
December 2, 2010

Generic versus branded medications in osteoporosis: Are they really similar?
December 2, 2010

Symposium on behalf of FIRMO, SIMG, SIOMMMS and SIOT under the auspices of ESCEO - Fragility Fractures: The Italian Effort for the Recognition of the Problem
May 8, 2010 (IOF WCO - ECCEO10)

ESCEO-ASBMR JOINT SYMPOSIUM - Rare Bone Disorders: Impact in Drug Development
May 8, 2010 (IOF WCO - ECCEO10)

ESCEO-GREES Roundtable - Relationship Between Pharmaceutical Industry and Academic Scientists: Suggestions for a New Code of Conduct
May 8, 2010 (IOF WCO - ECCEO10)

ESCEO-FROMO Session: Subtrochanteric Fractures After Long-Term Use of Bisphosphonates
May 7, 2010 (IOF WCO - ECCEO10)

ESCEO-FROMO Session: Management of Osteoporosis in the Very Elderly
May 7, 2010 (IOF WCO - ECCEO10)

ESCEO-FROMO Session: Dermatological Side Effects of Antiosteoporosis Medications
May 6, 2010 (IOF WCO - ECCEO10)

Subtrochanteric fractures after long-term treatment with bisphosphonates
January 9, 2010

Adverse reactions and drug-drug interactions in the management of osteoporosis
January 8, 2010

Long-term treatment with anti-osteoporosis drugs
December 12, 2009

Dermatological side effects of anti-osteoporosis treatment
April 1, 2009

Treatment of osteoporosis in the elderly
March 28, 2009

Management of the patient after a hip fracture
April 18, 2008

Calcium and Vitamin D
January 5, 2007

Osteonecrosis of the Jaw
December 14, 2006